Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...

It’s a simple question that physicians usually do not ask their patients: “When was your last drink?” “If the patient says yesterday, you know the patient isn’t a casual drinker,” said Joe G. Zein, MD ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...

A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Rare inherited genetic variants significantly increase familial lung cancer risk, offering new targets for early detection.

A new study led by researchers at Wake Forest University School of Medicine, in collaboration with the University of North ...